racemetirosine has been researched along with Movement Disorders in 3 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We therefore treated patients having various forms of dystonia and chorea with tetrabenazine (TBZ), and then added AMPT to determine if further improvement could be obtained." | 7.66 | Alpha methylparatyrosine and tetrabenazine in movement disorders. ( Lang, AE; Marsden, CD, 1982) |
| " We therefore treated patients having various forms of dystonia and chorea with tetrabenazine (TBZ), and then added AMPT to determine if further improvement could be obtained." | 3.66 | Alpha methylparatyrosine and tetrabenazine in movement disorders. ( Lang, AE; Marsden, CD, 1982) |
| "Acute dystonia can also be reliably induced in many primate species by neuroleptic treatment with comparable time course, symptomatology and pharmacological characteristics to those observed in man." | 2.37 | Acute dystonia induced by neuroleptic drugs. ( Jenner, P; Marsden, CD; Rupniak, NM, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lang, AE | 1 |
| Marsden, CD | 2 |
| Popoli, P | 1 |
| Caporali, MG | 1 |
| Scotti de Carolis, A | 1 |
| Rupniak, NM | 1 |
| Jenner, P | 1 |
1 review available for racemetirosine and Movement Disorders
| Article | Year |
|---|---|
Acute dystonia induced by neuroleptic drugs.
Topics: Acute Disease; alpha-Methyltyrosine; Animals; Antipsychotic Agents; Brain; Chlorpromazine; Disease M | 1986 |
2 other studies available for racemetirosine and Movement Disorders
| Article | Year |
|---|---|
Alpha methylparatyrosine and tetrabenazine in movement disorders.
Topics: Adult; alpha-Methyltyrosine; Chorea; Drug Therapy, Combination; Dystonia; Female; Humans; Male; Meth | 1982 |
Akinesia due to catecholamine depletion in mice is prevented by caffeine. Further evidence for an involvement of adenosinergic system in the control of motility.
Topics: Adenosine; alpha-Methyltyrosine; Animals; Caffeine; Catecholamines; Dose-Response Relationship, Drug | 1991 |